Myokardia Inc (MYOK)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
224.91 +0.11 (+0.05%) 11/16/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 224.91 unch (unch) -
for Mon, Nov 16th, 2020
Results
download Want to compare other data? Select FieldsSymbol | MYOK | BMRN | INCY | ||
Company | Myokardia Inc | Biomarin Pharmaceuticals | Incyte Corp | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 224.82 | 63.38 | 60.95 | ||
High | 225.00 | 64.00 | 62.87 | ||
Low | 224.52 | 62.80 | 59.76 | ||
Last | 224.91 | 63.69 | 62.66 | ||
Change | +0.11 | +0.41 | +2.23 | ||
% Change | +0.05% | +0.65% | +3.69% | ||
Volume | 2,702,300 | 1,296,500 | 2,822,400 | ||
20-Day Average Volume | 1,087,145 | 2,061,985 | 2,187,910 | ||
Previous Close | 224.80 | 63.28 | 60.43 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 223.67 | 60.97 | 59.00 | ||
20-Day Raw Stochastic | 97.10% | 63.52% | 90.91% | ||
20-Day Relative Strength | 86.21% | 49.00% | 52.30% | ||
Weighted Alpha | +89.80 | -22.90 | +6.86 | ||
Today's Opinion | 100% Buy | 56% Sell | 64% Sell | ||
Previous Opinion | 100% Buy | 56% Sell | 72% Sell | ||
Last Month's Opinion | 100% Buy | 8% Buy | 72% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.22% since 11/09/20 | +2.83% since 04/23/25 | +8.03% since 04/23/25 | ||
Low | 224.23 on 11/11/20 | 61.45 on 04/24/25 | 57.29 on 04/24/25 | ||
High | 225.00 on 11/16/20 | 64.08 on 04/29/25 | 62.87 on 04/30/25 | ||
1-Month | |||||
%Chg | +1.31% since 10/16/20 | -10.85% since 03/28/25 | +3.40% since 03/28/25 | ||
Low | 221.90 on 10/20/20 | 52.93 on 04/09/25 | 53.56 on 04/09/25 | ||
High | 225.00 on 11/16/20 | 71.28 on 03/31/25 | 63.57 on 04/04/25 | ||
3-Month | |||||
%Chg | +126.63% since 08/14/20 | -0.30% since 01/30/25 | -15.06% since 01/30/25 | ||
Low | 97.83 on 08/20/20 | 52.93 on 04/09/25 | 53.56 on 04/09/25 | ||
High | 225.00 on 11/16/20 | 73.51 on 03/07/25 | 76.96 on 02/07/25 | ||
6-Month | |||||
%Chg | +84.82% since 05/15/20 | -4.48% since 10/30/24 | -15.24% since 10/30/24 | ||
Low | 88.60 on 07/14/20 | 52.93 on 04/09/25 | 53.56 on 04/09/25 | ||
High | 225.00 on 11/16/20 | 73.51 on 03/07/25 | 83.95 on 11/08/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 11,992,876 | 12,074,078 | 11,694,655 | ||
Shares Outstanding, K | 53,323 | 190,804 | 193,524 | ||
Annual Sales | 0 | 2,853,920,000 | 4,241,220,000 | ||
Annual Net Income | -276,210,000 | 426,860,000 | 32,610,000 | ||
Last Quarter Sales | 0 | 747,310,000 | 1,178,700,000 | ||
Last Quarter Net Income | -84,740,000 | 124,940,000 | 201,210,000 | ||
60-Month Beta | 1.84 | 0.30 | 0.89 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | 0.92 on 02/19/25 | 1.16 on 04/29/25 | ||
Latest Earnings Date | 11/09/20 | 05/01/25 | 04/29/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 23.15 | 350.12 |